9MW2921

· Mabwell (Shanghai) Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 9MW2921, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]